3 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
Follow Amyloidosis: new trials by email Literature Review of Amyloidosis trials Research Report on Amyloidosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| N-of-1 for Beta-Blockers in Cardiac Amyloidosis Beta blocker - Cardiac Amyloidosis, Heart Diseases | Phase 4 | Completed | Weill Medical College of Cornell University | 14 | 2024-01-31 | 2026-07-29 |
| The Effect Of Tafamidis Meglumine In Transthyretin Amyloid Polyneuropathy Patients tafamidis meglumine - Transthyretin Amyloid Polyneuropathy (ATTR-PN) | Phase 4 | Completed | Pfizer | 15 | 2021-04-28 | 2024-03-12 |
| Imaging Cardiac Amyloidosis: A Pilot Study Using F-18 Florbetapir Positron Emission Tomography F-18 florbetapir PET - Cardiac Amyloidosis | Phase 4 | Completed | Brigham and Women's Hospital | 23 | 2013-03-23 | 2025-11-20 |
Amyloid Neuropathies, Familial (3) · Disease (1) · Heart Diseases (1) · Heart Failure (1)
Amyloid Neuropathies (3) · Amyloidosis, Familial (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genetic Diseases, Inborn (3) · Heredodegenerative Disorders, Nervous System (3) · Metabolic Diseases (3) · Metabolism, Inborn Errors (3) · Nervous System Diseases (3) · Neurodegenerative Diseases (3) · Neuromuscular Diseases (3) · Nutritional and Metabolic Diseases (3) · Peripheral Nervous System Diseases (3) · Proteostasis Deficiencies (3) · Cardiovascular Diseases (1)
Adrenergic beta-Antagonists (1) · tafamidis (1)
Brigham and Women's Hospital (1) · Pfizer (1) · Weill Medical College of Cornell University (1)
United States (2) · China (1)
Parag Goyal, MD, MSc (1) · Sharmila Dorbala, MBBS, MPH (1)
R24AG064025 (1)